Reduction of blood pressure retards the progression of chronic renal failure in man

Nephrology Dialysis Transplantation

Volumn 3, Issue 5, 1988, Pages 624-631

  Alvestrand, A ^a   Gutierrez, A ^a   Bucht, H ^a   Bergstrom, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic renal failure; Glomerulonephritis; Hypertension; Proteinuria

Indexed keywords

BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 0024209682     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a091717     Document Type: Article

References (29)

1. Meyer TW, Brenner BM. The contribution of glomerular hemo-dynamic alterations to progressive renal disease. In: Mitch WE, ed. The Progressive Nature of Renal Disease. New York: Churchill Livingstone, 1986: 1-16
2. Mitch WE, Walser M, Buffington GA, Lemann J Jr. A simple method for estimating progression of chronic renal failure. Lancet 1976; 2:1326-1328
3. Adler SG, Kopple JD. Factors influencing the progression of renal insufficiency. Semin Nephrol 1983; 3: 335-345
4. Baldwin DS. Chronic glomerulonephritis: Nonimmunologic mechanisms of progressive glomerular damage. Kidney Int 1982; 21: 109-120
5. van der Peet J, Arisz L, Brentjens JRH, Marrink J, Hoedmaxker PJ. The clinical course of IgA nephropathy in adults. Clin Nephrol 1977; 8: 335-340
6. Oldrizzi L, Rugiu C, Valvo E et al. Progression of renal failure in patients with renal disease of diverse etiology on protein restricted diet. Kidney Int 1985; 27: 553-557
7. Kajiwara N. Therapy and prognosis of hypertension in chronic nephritis. Jpn Circ J 1975; 39: 779-786
8. Siman HB, Thompson GJ. Congenital renal polycystic disease. JAMA 1955; 159: 657-662
9. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619
10. Raij L, Chiou X-C, Owens R, Wrigley B. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine and hydrochlorthiazide in an experimental model. Am J Med. 1985; 79 [suppl 3C]: 37-41
11. Mroczek WJ, Davidov M, Gavrilovich L. Finnerty FA. The value of aggressive therapy in the hypertensive patient with azotemia. Circulation 1969; 40: 893-904
12. Pohl JEF, Thurson H, Swales JD. Hypertension with renal impair-ment: Influence of intensive therapy. Q J Med 1974; 43: 569-581
13. Devine BL, Fife R, Trust PM. Minoxidil for severe hypertension? after failure of other hypotensive drugs. Br Med J 1977; 2:667-669
14. Curtis JR, Bateman FJA. Use of prazosin in management of hyper-tension in patients with chronic renal failure and in renal transplant recipients. Br Med J 1975; 4: 432-434
15. Mogensen CE. Long-term antihypertensive treatment (over six years) inhibiting the progression of diabetic nephropathy. Acta Endocrinol 1981; [suppl] 242: 31-32
16. Parving H-H, Andersen AR, Smith UM, Christiansen JS, Oxenboll B, Svendsen PA. Diabetic nephropathy and arterial hypertension: The effect of antihypertensive treatment. Diabetes 1983; 32 [suppl. 2]: 83-87
17. Branca GF, Satta A, Faedda R et al. Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure. Panminerva Med 1983; 25: 215-218
18. Friedlaender MM, Rubinger D, Popovtzer MM. Improved renal function in patients with primary renal disease after control of severe hypertension. Am J Nephrol 1982; 2: 12-14
19. Bergström J, Alvestrand A, Bucht H, Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986; 25: 1-6
20. Borah MF, Schoenefeld PY, Gotch FA, Sargent FJA, Wolfson M, Humphreys MH. Nitrogen balance during intermittent-dialysis therapy of uremia. Kidney Int 1978; 14:491-500
21. Hostetter TH, Olson JL. Rennek MA, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: A potentially adverse effect to renal ablation. Am J Physiol 1981; 241: F85-F93
22. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM. Hemody-namic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 1984; 73: 1448-1461
23. Azar S, Johnson MA, Iwai J, Bruno L, Tobian L. Single nephron dynamics in “post-salt” rats with chronic hypertension. J Lab Clin Werf 1978:91:156-166
24. Gottschalk CW. Function of the chronically diseased kidney. The adaptive nephron. Circ Res 1971: 28 [suppl. II]: II 1-II 13
25. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000
26. Rabkin R, Petersen J, Kitaji J, Marek B. Murphy W, Muirhead EE. Effect of antihypertensive therapy on the kidney in spontaneously hypertensive rats with diabetes. Kidney Int 1984; 25: 205a (abstr)
27. Mogensen CE, Christensen CK. Blood pressure changes and renal function in incipient and overt diabetic nephropathy. Hypertension 1985; 7 [suppl II]: 1164-1173
28. Christensen CK, Mogensen CE. Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 1985: 7 [suppl II]: II 109-II 113
29. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-1930